(9/9) Our results show a new cell-autonomous mechanism to activate the IFN-I response in microglia. Interestingly, some PHD inhibitors are already in clinical use, and it would be interesting to see if they can improve microglial responses to Aß plaques.
29.05.2025 12:49 — 👍 0 🔁 0 💬 0 📌 0
(8/9) Mechanistically, FOXO3 –a transcriptional repressor of the IFN response– stability is regulated by PHD3. Interestingly, FOXO3 has been identified in human studies as a key factor in microglial responses doi.org/10.1016/j.ce..., and we now show that FOXO3 is associated with the IFN response.
29.05.2025 12:48 — 👍 1 🔁 0 💬 1 📌 0
(7/9) PHD3 deficiency correlates with a decrease in the AD microglia type-I IFN responses, decreased local Aß plaque pathology, and a rescue of the behavioral defects in AD mouse models.
29.05.2025 12:45 — 👍 1 🔁 0 💬 1 📌 0
(6/9) We now describe a new pathway that activates type-I IFN response in microglia controlled by HIF1 and PHD3, a transcriptional target of HIF1.
29.05.2025 12:45 — 👍 0 🔁 0 💬 1 📌 0
(3/9) It has been nicely demonstrated that microglial type-I IFN response is required for normal physiology and can be detrimental to the brain in chronic neurodegenerative diseases. The main controller of this response is the cGAS-STING pathway (see, for instance, www.cell.com/trends/neuro...
29.05.2025 12:42 — 👍 1 🔁 0 💬 1 📌 0
(2/9) We have characterized an unexpected cell-autonomous system to induce type-I interferon response in AD microglia.
29.05.2025 12:41 — 👍 1 🔁 0 💬 1 📌 0
Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer’s disease progression
PHD3 inhibition slows down the pathology and behavioral decline of an Alzheimer’s disease mouse model.
Really happy to see our work on Alzheimer’s disease (AD) microglia published in @science.org www.science.org/doi/10.1126/.... A great work at IBiS from Manuel Sanchez-Garcia, Nieves Lara-Ureña, Rosana March-Diaz, @alicielena.bsky.social , and all our collaborators.
29.05.2025 12:40 — 👍 3 🔁 2 💬 3 📌 1
Cuenta oficial del Consorcio Centro de Investigación Biomédica en Red, CIBER del Instituto de Salud Carlos III. Nuestro objetivo es impulsar la investigación en Biomedicina y Ciencias de la Salud.
Web: https://www.ciberisciii.es/
Developmental neurobiologist.
Neurogenesis, neurodevelopmental disorders & evolution.
Group leader in a hotel named IBIS. I'm serious.
🇻🇪 born 🇺🇸 lived 🇪🇸 living
Mom - Scientist - Feminist
She/her
Neuroscientist at Spanish National Research Council (CSIC) @csic.es - Instituto de Neurociencias (UMH-CSIC) @neuroalc.bsky.social || https://in.umh-csic.es/en/grupos/cellular-plasticity-and-neuropathology/ || Sapere aude
Research professor at Achucarro Basque Center for Neuroscience. Microglial lover, passionate about science outreach.
ORCID: 0000-0001-8415-096X
Lab website: https://www.achucarro.org/es/laboratory/glial-cell-biology/
Cell Press partners with scientists across all disciplines to publish and share work that will inspire future directions in research. #ScienceThatInspires
Lab @ Unity Health Toronto/University of Toronto & UK Dementia Research Institute/ University of Edinburgh studying myelin health across the lifespan.
John David Eaton Chair of MS Research/
MRC Senior Fellow
www.mironlab.ca
News, commentary and research coverage from the international monthly journal publishing the highest quality of work in all areas of neuroscience.
https://www.nature.com/neuro/
Neuroimmunologist studying MS, autism, Alzheimer's disease, and brain injury at the University of Virginia. Father of two. Fan of Philly sports and US soccer.
www.lukenslab.com
official Bluesky account (check username👆)
Bugs, feature requests, feedback: support@bsky.app